Reye’s Syndrome Warning Will Not Apply To Salicylate Inactive Ingredients
This article was originally published in The Tan Sheet
Executive Summary
OTC drugs containing salicylates as inactive ingredients will not be required to carry a Reye's syndrome warning in their labeling, according to a final rule published in the April 17 Federal Register